Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 166.66 +4.07 (2.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $162.59 | 52 Week High | $5.84 | |||
| Open | $162.29 | 52 Week Low | $5.49 | |||
| Day High | $171.22 | P/E | N/A | |||
| Day Low | $162.00 | EPS | $0.00 | |||
| Volume | 2,535,627 | |||||
